|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,972.50 GBX | +1.15% |
|
+2.65% | +8.11% |
| 06-17 | GSK says US FDA approves urinary tract infection treatment Utebzi | AN |
| 06-17 | GSK plc Receives US FDA Approval for Oral Antibiotic Tebipenem for Complicated Urinary Tract Infections | CI |
EPS & Dividend: GSK plc
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Dividend per Share 2 | 1 | 0.6125 | 0.58 | 0.61 | 0.66 | 0.7006 | 0.7328 | 0.763 |
| Rate of return | 4.98% | 4.26% | 4% | 4.53% | 3.62% | 3.55% | 3.72% | 3.87% |
| EPS 2 | 1.082 | 3.662 | 1.216 | 0.632 | 1.411 | 1.558 | 1.682 | 1.725 |
| Distribution rate | 92.4% | 16.7% | 47.7% | 96.5% | 46.8% | 45% | 43.6% | 44.2% |
| Reference price 2 | 20.08 | 14.38 | 14.50 | 13.46 | 18.24 | 19.72 | 19.72 | 19.72 |
| Nbr of stocks (in thousands) | 4,006,383 | 4,060,999 | 4,076,145 | 4,080,519 | 4,012,126 | 3,991,951 | - | - |
| Announcement Date | 09/02/22 | 01/02/23 | 31/01/24 | 05/02/25 | 04/02/26 | - | - | - |
Past dividends: GSK plc
| 14/05/2026 | Ex-dividend date - 0.17 GBX | 05:00 |
| 19/02/2026 | Ex-dividend date - 0.18 GBX | 05:00 |
| 13/11/2025 | Ex-dividend date - 0.16 GBX | 05:00 |
| 14/08/2025 | Ex-dividend date - 0.16 GBX | 05:00 |
Upcoming Events: GSK plc
| 28/07/2026 | Earnings release | Q2 2026 | |
| 28/10/2026 | Earnings release | Q3 2026 | Day |
| 03/02/2027 | Earnings release | Q4 2026 | Day |
| Dividend Yield (N) | Dividend Yield (N+1) | P/E (N) | Price to Book (N) | EV / Sales (N) | ||
|---|---|---|---|---|---|---|
| 3.59% | 3.76% | 12.52x | 4.63x | 2.73x | ||
| 0.61% | 0.67% | 32.85x | 19.6x | 11.94x | ||
| 2.27% | 2.37% | 25.13x | 6.33x | 5.79x | ||
| 3.09% | 3.25% | 27.6x | -809.84x | 6.65x | ||
| 3.09% | 3.17% | 17.38x | 6.41x | 4.29x | ||
| 1.87% | 1.98% | 22.34x | 5.2x | 4.67x | ||
| 2.97% | 3.05% | 20.88x | 6.26x | 5.41x | ||
| 4.05% | 3.88% | 12.39x | 5.42x | 4.65x | ||
| 2.9% | 3.06% | 22.62x | 16.86x | 6.06x | ||
| 2.55% | 2.61% | -45.59x | 8.64x | 5.5x | ||
| Average | 2.7% | 2.78% | 14.81x | -73.05x | 5.77x | |
| Weighted average by Cap. | 2.18% | 2.26% | 21.91x | -81.17x | 7.22x |
Year-on-year evolution of the Yield
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Estimates Revisions
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
Annual Profit -
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















